(1R,3S)-5-((Z,2E)-4-((1S,3S)-3-(4-hydroxy-4-methylpentyl)-1,2,2-trimethylcyclopentyl)-2-butenylidene)-4-methylenecyclohexane-1,3-diol,
KS 176,
KS176,
1253452-78-6,
KS 176,
KS-176,
N-[4-(2-hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]benzamide,
GTPL10006,
EX-A807,
BCP17744,
MFCD22666402,
ZINC86032128,
AKOS024458013,
CS-5435,
NCGC00379100-01,
AK546306,
HY-19753,
KS-176, >=98% (HPLC),
FT-0700436,
J-690102,
N-[4-(2-hydroxyethyl)phenyl]-2-(4-nitrobenzamido)benzamide,
Benzamide, N-[4-(2-hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]-,
Taselisib,
A16195,